Microvision (NASDAQ:MVIS) announces earnings results

MicroVision (NASDAQ: MVIS – Get Rating) released its quarterly earnings results on Thursday. The electronics maker reported earnings per share ($0.08) for the quarter, above analysts’ consensus estimate ($0.07) ($0.01), reports RTT News. MicroVision had a negative return on equity of 36.14% and a negative net margin of 2,114.59%. During the same period last year, the company posted EPS ($0.04).

Microvision Price Display

NASDAQ: MVIS traded at $0.14 during trading hours on Friday, reaching $5.15. 5,511,351 shares of the stock were exchanged, while its average volume was 4,336,833. Microvision has a twelve-month low of $2.50 and a twelve-month high of $16.38. The firm’s 50-day moving average is $4.12 and the 200-day moving average is $3.85. The stock has a market cap of $850.83 million, a PE ratio of -16.58 and a beta of 3.28.

Hedge funds weigh in on Microvision

Several large investors have bought and sold shares of MVIS recently. JPMorgan Chase & Co increased its stake in Microvision’s shares by 173.5% in the first quarter. JPMorgan Chase & Co now owns 754,113 shares of the electronics maker’s stock, valued at $3,521,000, after purchasing an additional 478,420 shares during the previous quarter. Raymond James & Associates acquired a new stake in Microvision’s shares worth approximately $56,000 in the first quarter. Citerra Advisor Networks LLC raised its stake in Microvision’s shares by 145.9% in the first quarter. Setera Advisor Networks LLC now holds 38,763 shares of the electronics maker’s stock worth $181,000 after purchasing an additional 23,000 shares during the previous quarter. Private Advisory Group LLC increased its stake in Microvision’s shares to 82.4% in the first quarter. Private Advisory Group LLC now holds 46,464 shares of the electronics maker’s stock worth $217,000 after purchasing an additional 20,984 shares during the previous quarter. Finally, MetLife Investment Management LLC increased its stake in Microvision’s shares to 83.1% in the first quarter. MetLife Investment Management LLC now owns 78,610 shares of the electronics maker’s stock worth $367,000 after purchasing an additional 35,677 shares during the previous quarter. Institutional investors and hedge funds own 28.72% of the company’s shares.

Read |  Date: August 02, 2022 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K

About Microvision (Get Rating)

advertising legacy research

“I only trade one stock and I never worry about it…”

The name of One Stock (ticker symbol and all) that has helped over 170,000 people figure out how to achieve their financial independence…

Microvision, Inc. develops lidar sensors used in automotive safety and autonomous driving applications. Its laser beam scanning technology is based on micro-electrical mechanical systems, laser diodes, opto-mechanics, electronics, algorithms and software. The company also develops micro-display concepts and designs for head-mounted augmented reality (AR) headsets, as well as a 1440i MEMS module that can support AR headsets; Interactive display modules used in smart speakers and other devices; and used in consumer lidar smart home systems.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat to provide readers with the fastest and most accurate reporting. This story was reviewed by Marketbeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should You Invest $1,000 in Microvision Now?

Before you consider MicroVision, you might want to hear this.

MarketBeat tracks Wall Street’s top-rated and best-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified five stocks that top analysts are quietly whispering to their clients to buy before the broader market catches on… and Microvision wasn’t on the list.

While Microvision currently has a “hold” rating among analysts, top-rated analysts believe these five stocks are the better buy.

View 5 stocks here

Source link

Read |  Index: Stock Market Updates: Nifty Pharma Index fell 0.26% in an upbeat market